BlackRock Portfolio holdings
BlackRock is an asset manager that runs the iShares family of exchange-traded funds. It was founded in 1988 by Larry Fink, a mortgage-bond pioneer at First Boston, and several colleagues, to manage money for institutions with a focus on risk. Blackstone backed the start-up in exchange for a stake in its bond business, and the two parted ways in 1994. BlackRock went public in 1999 and merged with the investment managers division of Merrill in 2006. BlackRock bought the iShares business from Barclays in 2010 and the private credit manager HPS Investment Partners in 2025. It also sells technology: its Aladdin platform gives institutional investors tools for portfolio management, risk analysis, trading and accounting, and its BlackRock Solutions unit, launched in 2000, advises on risk management.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
SpaceX
SPCX
|
+$8.67B |
| 2 |
Microsoft
MSFT
|
+$5.68B |
| 3 |
HONA
Honeywell Aerospace
HONA
|
+$5.24B |
| 4 |
Apple
AAPL
|
+$5.23B |
| 5 |
Alphabet (Google) Class A
GOOGL
|
+$5.04B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Honeywell
HON
|
+$5.81B |
| 2 |
Coterra Energy
CTRA
|
+$2.24B |
| 3 |
Intel
INTC
|
+$2.13B |
| 4 |
Qualcomm
QCOM
|
+$2.03B |
| 5 |
Hologic
HOLX
|
+$1.7B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 34.75% |
| 2 | Financials | 11.04% |
| 3 | Industrials | 9.81% |
| 4 | Healthcare | 9.52% |
| 5 | Consumer Discretionary | 8.7% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
3126
Nature's Sunshine
NATR
$191M
| $21.6M | ﹤0.01% |
989,020
-75,434
| -7% | -$1.76M |
2013 Q2
52 quarters
|
|
3127
Rocky Brands
RCKY
$404M
| $21.6M | ﹤0.01% |
522,760
+29,464
| +6% | +$1.15M |
2017 Q1
37 quarters
|
|
3128
Aeluma Inc
ALMU
$144M
| $21.5M | ﹤0.01% |
973,235
+113,528
| +13% | +$2.43M |
2025 Q2
4 quarters
|
|
3129
Oppenheimer Holdings
OPY
$993M
| $21.5M | ﹤0.01% |
203,463
+16,397
| +9% | +$1.67M |
2013 Q2
52 quarters
|
|
3130
Cadiz
CDZI
$321M
| $21.5M | ﹤0.01% |
5,135,402
+1,307,115
| +34% | +$5.83M |
2017 Q1
37 quarters
|
|
3131
John Marshall Bancorp
JMSB
$327M
| $21.5M | ﹤0.01% |
984,411
+109,048
| +12% | +$2.31M |
2022 Q2
16 quarters
|
|
3132
Ardent Health
ARDT
$2.53B
| $21.4M | ﹤0.01% |
2,176,348
+418,133
| +24% | +$3.96M |
2024 Q3
7 quarters
|
|
3133
Zura Bio
ZURA
$119M
| $21.3M | ﹤0.01% |
3,614,695
+3,157,336
| +690% | +$15M |
2023 Q2
12 quarters
|
|
3134
Onity Group
ONIT
$268M
| $21.3M | ﹤0.01% |
536,385
+44,583
| +9% | +$1.76M |
2013 Q2
52 quarters
|
|
3135
MoonLake Immunotherapeutics
MLTX
$1.07B
| $21.3M | ﹤0.01% |
1,094,791
+72,940
| +7% | +$1.32M |
2020 Q4
22 quarters
|
|
3136
Sasol
SSL
$8.84B
| $21.3M | ﹤0.01% |
2,169,866
+94,684
| +5% | +$1.2M |
2021 Q1
21 quarters
|
|
3137
QuickLogic
QUIK
$155M
| $21.3M | ﹤0.01% |
1,065,055
+904,758
| +564% | +$15.8M |
2017 Q1
37 quarters
|
|
3138
Jack in the Box
JACK
$284M
| $21.2M | ﹤0.01% |
1,342,305
+60,689
| +5% | +$748K |
2013 Q2
52 quarters
|
|
3139
FS Bancorp
FSBW
$344M
| $21.2M | ﹤0.01% |
488,775
+51,988
| +12% | +$2.13M |
2017 Q1
37 quarters
|
|
3140
Anika Therapeutics
ANIK
$195M
| $21.2M | ﹤0.01% |
1,449,671
-145,222
| -9% | -$2.15M |
2013 Q2
52 quarters
|
|
3141
Blue Owl Capital
OBDC
$5.47B
| $21.1M | ﹤0.01% |
1,945,430
-44,797
| -2% | -$501K |
2019 Q3
27 quarters
|
|
3142
SharonAI Holdings
SHAZ
$857M
| $21.1M | ﹤0.01% |
+249,109
| New | +$14.1M |
2026 Q2
0 quarters
|
|
3143
Assembly Biosciences
ASMB
$444M
| $21.1M | ﹤0.01% |
766,819
+564,076
| +278% | +$15.4M |
2017 Q1
37 quarters
|
|
3144
EVgo
EVGO
$261M
| $21M | ﹤0.01% |
11,010,380
+196,575
| +2% | +$396K |
2021 Q1
21 quarters
|
|
3145
Ares Commercial Real Estate
ACRE
$204M
| $21M | ﹤0.01% |
4,672,092
+157,631
| +3% | +$778K |
2013 Q4
50 quarters
|
|
3146
Main Street Capital
MAIN
$5.36B
| $20.9M | ﹤0.01% |
403,623
-20,612
| -5% | -$1.09M |
2017 Q1
37 quarters
|
|
3147
Anavex Life Sciences
AVXL
$113M
| $20.9M | ﹤0.01% |
8,055,628
+446,010
| +6% | +$1.32M |
2016 Q2
40 quarters
|
|
3148
iShares BBB Rated Corporate Bond ETF
LQDB
$58.5M
| $20.8M | ﹤0.01% |
240,000
-10,000
| -4% | -$863K |
2021 Q2
20 quarters
|
|
3149
TPG Mortgage Investment Trust
MITT
$145M
| $20.7M | ﹤0.01% |
2,618,326
+149,083
| +6% | +$1.16M |
2013 Q2
52 quarters
|
|
3150
Abeona Therapeutics
ABEO
$157M
| $20.7M | ﹤0.01% |
3,352,474
+156,944
| +5% | +$862K |
2017 Q1
37 quarters
|
|
Similar funds
BlackRock's Q2 2026 Portfolio in Review
As of Q2 2026, BlackRock held 5,933 positions worth $6.73T, up 18% from $5.72T the previous quarter. Its ten largest holdings account for 28% of the portfolio.
BlackRock's Q2 2026 filing shows 244 new, 3,464 increased, 1,293 reduced and 235 closed positions. Its largest new stake was SpaceX: 51,037,137 shares worth $8.72B. The largest sale was Honeywell, an estimated $5.81B.
By sector, the portfolio is most concentrated in Technology at 35% of assets, up from 30% a quarter earlier, followed by Financials and Industrials.
- BlackRock's largest Q2 2026 buy was SpaceX: 51,037,137 shares worth $8.72B.
- BlackRock added most to Microsoft in Q2 2026, an estimated $5.68B increase.
- BlackRock's biggest Q2 2026 reduction was Honeywell, cutting an estimated $5.81B.
- BlackRock fully exited Coterra Energy in Q2 2026, selling an estimated $2.24B.
- BlackRock's ten largest holdings make up 28% of its $6.73T portfolio in Q2 2026.
- BlackRock opened 244 new positions and closed 235 in Q2 2026.
- BlackRock's portfolio value rose 18% quarter-over-quarter to $6.73T.
Based on BlackRock's 13F filing for Q2 2026, filed 7 Aug 2026.